Login
$CDT
$0.38 +$0.00 (0.8%) After hours

$CDT 8-K SEC Filings

Filed On Filing
16 Nov 2026 8-K: Submission of Matters to a Vote of Security Holders

Date of Report (Date of earliest event reported): November 12, 2026

09 Nov 2026 8-K: Other Events

On November 5, 2026, Dr. Andrew Regan, the former CEO of CDT Equity Inc. (the “Company”), delivered a letter to the Company’s Board of Directors (the “Board”) as a significant stockholder of the Company, through his own shareholding and ...

04 Nov 2026 8-K: Material Modification to Rights of Security Holders; Amendments to Articles/Bylaws; Change in Fiscal Year

(Pursuant to Section 242 of the General Corporation Law of the State of Delaware)

27 Oct 2026 8-K: Entry into a Material Definitive Agreement; Unregistered Sales of Equity Securities +1 more

This Evaluation Agreement (the “Agreement”) is made on October 22, 2026 (the “Effective Date”).

13 Oct 2026 8-K: Entry into a Material Definitive Agreement; Creation of a Direct Financial Obligation +1 more

THIS SECURITY HAS NOT BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT...

25 Sep 2026 8-K: Material Modification to Rights of Security Holders; Amendments to Articles/Bylaws; Change in Fiscal Year +1 more

(Pursuant to Section 242 of the General Corporation Law of the State of Delaware)

18 Sep 2026 8-K: Entry into a Material Definitive Agreement; Creation of a Direct Financial Obligation +1 more

THIS SECURITY HAS NOT BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT...

04 Sep 2026 8-K: Entry into a Material Definitive Agreement; Creation of a Direct Financial Obligation +1 more

THIS SECURITY HAS NOT BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT...

01 Sep 2026 8-K: Other Events

As previously disclosed, on August 28, 2026, at the 2026 Annual Meeting of Stockholders (the “Annual Meeting”) of CDT Equity Inc. (the “Company”), stockholders approved the issuance of shares of common stock, par value $0.0001 per share ...

01 Sep 2026 8-K: Departure/Election of Directors or Officers; Compensation; Submission of Matters to a Vote of Security Holders

CDT Equity Inc. of 4851 Tamiami Trail North, Suite 200, Naples, FL 34103 (the “Company”) is pleased to offer you a position on the terms set forth in this letter (this “Agreement”), effective as of the date of this letter (the “Effective...

06 Aug 2026 8-K: Entry into a Material Definitive Agreement; Creation of a Direct Financial Obligation +1 more

This Second Amendment to Loan Agreement and Second Amendment to Senior Secured Convertible Note (this “Amendment”) is entered into as of July 31, 2026 (the “Amendment Date”), by and among:

31 Jul 2026 8-K: Entry into a Material Definitive Agreement; Unregistered Sales of Equity Securities

THIS SECURITIES PURCHASE AGREEMENT, dated as of July 30, 2026 (this “Agreement”), is entered into by and among CDT Equity Inc., a Delaware corporation (the “Company”), and the investor identified on the signature page hereto (each, inclu...

29 Jul 2026 8-K: Unregistered Sales of Equity Securities

On July 24, 2026, CDT Equity, Inc. (the “Company”) issued 32,110 shares of common stock, par value $0.0001 per share (the “Common Stock”) at a value of $3.27 per share to a service provider as consideration for certain consulting service...

16 Jul 2026 8-K: Material Modification to Rights of Security Holders; Amendments to Articles/Bylaws; Change in Fiscal Year +1 more

(Pursuant to Section 242 of the General Corporation Law of the State of Delaware)

07 Jul 2026 8-K: Entry into a Material Definitive Agreement; Creation of a Direct Financial Obligation

This Amended and Restated Loan Agreement (this “Agreement”) is dated as of June 30, 2026 (the “Agreement Date”) and is made and entered into between CDT Equity Inc., (formerly Conduit Pharmaceuticals Inc.) a Delaware corporation (the “Co...

29 Jun 2026 8-K: Changes in Registrant's Certifying Accountant

We have read the statements made by CDT Equity Inc. under Item 4.01 of its Form 8-K dated June 29, 2026. We agree with the statements concerning our Firm in such Form 8-K; we are not in a position to agree or disagree with other statemen...

16 Jun 2026 8-K: Entry into a Material Definitive Agreement; Creation of a Direct Financial Obligation +2 more

This Loan Agreement (this “Agreement”) is dated as of June 11, 2026 (the “Agreement Date”) and is made and entered into between CDT Equity Inc., (formerly Conduit Pharmaceuticals Inc.) a Delaware corporation (the “Company”), and J.J. Ast...

28 May 2026 8-K: Notice of Delisting or Failure to Satisfy a Listing Rule; Regulation FD Disclosure

NAPLES, Fla. and CAMBRIDGE, United Kingdom, May 28, 2026 (GLOBE NEWSWIRE) — CDT Equity Inc. (Nasdaq: CDT) (“CDT” or the “Company”), today announced that the Company received a written notice (“Notice”) from the Nasdaq Listing Qualificati...

15 May 2026 8-K: Entry into a Material Definitive Agreement

Reference is made to the Directed Stock Purchase Agreement, dated as of January 16, 2026 (as modified to the date hereof, the “Purchase Agreement”), by and among CDT Equity, Inc., a Delaware corporation (together with its successors and ...

27 Apr 2026 8-K: Departure/Election of Directors or Officers; Compensation

On April 27, 2026, upon the recommendation of the Nominating and Corporate Governance Committee, the Board of Directors (the “Board”) of CDT Equity Inc. (the “Company”) appointed Ulrik Olsen as a director of the Company, and as a member ...

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support